Arkolith/Insider Trading/FDMT/Form 4

Kirn David

See Remarks, Director4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jul 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$737K
Net Open-Market Flow
-$737K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Sell(S)15K$12.01$184K885K
Jul 10, 2026Sell(S)442$12.84$6K884K
Jul 9, 2026Sell(S)43K$12.87$548K900K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001834021-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML